Article

Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study

Northwestern University, Chicago, Illinois, USA.
Journal of the American Medical Informatics Association (Impact Factor: 3.93). 11/2011; 19(2):212-8. DOI: 10.1136/amiajnl-2011-000439
Source: PubMed

ABSTRACT Genome-wide association studies (GWAS) require high specificity and large numbers of subjects to identify genotype-phenotype correlations accurately. The aim of this study was to identify type 2 diabetes (T2D) cases and controls for a GWAS, using data captured through routine clinical care across five institutions using different electronic medical record (EMR) systems.
An algorithm was developed to identify T2D cases and controls based on a combination of diagnoses, medications, and laboratory results. The performance of the algorithm was validated at three of the five participating institutions compared against clinician review. A GWAS was subsequently performed using cases and controls identified by the algorithm, with samples pooled across all five institutions.
The algorithm achieved 98% and 100% positive predictive values for the identification of diabetic cases and controls, respectively, as compared against clinician review. By standardizing and applying the algorithm across institutions, 3353 cases and 3352 controls were identified. Subsequent GWAS using data from five institutions replicated the TCF7L2 gene variant (rs7903146) previously associated with T2D.
By applying stringent criteria to EMR data collected through routine clinical care, cases and controls for a GWAS were identified that subsequently replicated a known genetic variant. The use of standard terminologies to define data elements enabled pooling of subjects and data across five different institutions to achieve the robust numbers required for GWAS.
An algorithm using commonly available data from five different EMR can accurately identify T2D cases and controls for genetic study across multiple institutions.

Download full-text

Full-text

Available from: Christopher Carlson, Sep 02, 2015
1 Follower
 · 
206 Views
 · 
45 Downloads
  • Source
    • "The first VGER cohort (VGER-660) was comprised predominantly of EMR-defined white European ancestry subjects (N = 3,174), and the second (VGER-1M) was comprised predominantly of EMR-defined black African American subjects (n = 1,558). These cohorts were selected for genotyping using phenotype selection algorithms that identified individuals with normal cardiac conduction or type 2 diabetes (and their controls) [5], [25]. Subjects in the third cohort were selected from BioVU by an ongoing study (Vanderbilt Electronic Systems for Pharmacogenomic Assessment; VESPA) examining the genomics of drug response [26] (n = 3,940; Table S1). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The coupling of electronic medical records (EMR) with genetic data has created the potential for implementing reverse genetic approaches in humans, whereby the function of a gene is inferred from the shared pattern of morbidity among homozygotes of a genetic variant. We explored the feasibility of this approach to identify phenotypes associated with low frequency variants using Vanderbilt's EMR-based BioVU resource. We analyzed 1,658 low frequency non-synonymous SNPs (nsSNPs) with a minor allele frequency (MAF)<10% collected on 8,546 subjects. For each nsSNP, we identified diagnoses shared by at least 2 minor allele homozygotes and with an association p<0.05. The diagnoses were reviewed by a clinician to ascertain whether they may share a common mechanistic basis. While a number of biologically compelling clinical patterns of association were observed, the frequency of these associations was identical to that observed using genotype-permuted data sets, indicating that the associations were likely due to chance. To refine our analysis associations, we then restricted the analysis to 711 nsSNPs in genes with phenotypes in the On-line Mendelian Inheritance in Man (OMIM) or knock-out mouse phenotype databases. An initial comparison of the EMR diagnoses to the known in vivo functions of the gene identified 25 candidate nsSNPs, 19 of which had significant genotype-phenotype associations when tested using matched controls. Twleve of the 19 nsSNPs associations were confirmed by a detailed record review. Four of 12 nsSNP-phenotype associations were successfully replicated in an independent data set: thrombosis (F5,rs6031), seizures/convulsions (GPR98,rs13157270), macular degeneration (CNGB3,rs3735972), and GI bleeding (HGFAC,rs16844401). These analyses demonstrate the feasibility and challenges of using reverse genetics approaches to identify novel gene-phenotype associations in human subjects using low frequency variants. As increasing amounts of rare variant data are generated from modern genotyping and sequence platforms, model organism data may be an important tool to enable discovery.
    PLoS ONE 06/2014; 9(6):e100322. DOI:10.1371/journal.pone.0100322 · 3.23 Impact Factor
  • Source
    • "African ancestry. eMERGE I has already contributed genomewide associated variants (at a threshold of p < 10 −5 ) in participants of African ancestry to the NHGRI GWAS Catalog for LDL-C (Rasmussen-Torvik et al., 2012), red blood cell traits (Ding et al., 2013), white blood cell traits (Crosslin et al., 2012), type 2 diabetes (Kho et al., 2012), and electrocardiographic traits (Jeff et al., 2013). As an extension of GWAS, eMERGE investigators have also begun fine-mapping GWAS-identified regions to identify the best index variant in African ancestry populations as well as exploring alternative genomic discovery methods such as admixture mapping to identify potentially novel or populationspecific associations (Jeff et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The electronic MEdical Records & GEnomics (eMERGE) network was established in 2007 by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) in part to explore the utility of electronic medical records (EMRs) in genome science. The initial focus was on discovery primarily using the genome-wide association paradigm, but more recently, the network has begun evaluating mechanisms to implement new genomic information coupled to clinical decision support into EMRs. Herein, we describe this evolution including the development of the individual and merged eMERGE genomic datasets, the contribution the network has made toward genomic discovery and human health, and the steps taken toward the next generation genotype-phenotype association studies and clinical implementation.
    Frontiers in Genetics 06/2014; 5:184. DOI:10.3389/fgene.2014.00184
  • Source
    • "For all continuous traits, only a single observation within the synthetic derivative was required for an individual to be included in the analysis. Cases and controls for T2D, were defined as previously described [22], except for the inclusion of those with a family history of diabetes as controls. Hypertension was dichotomized as case or control, in which cases were defined as having a systolic blood pressure greater than or equal to 140 mmHg, having a diastolic blood pressure greater than or equal to 90 mmHg, or currently taking any hypertension medication. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondria play a critical role in the cell and have DNA independent of the nuclear genome. There is much evidence that mitochondrial DNA (mtDNA) variation plays a role in human health and disease, however, this area of investigation has lagged behind research into the role of nuclear genetic variation on complex traits and phenotypic outcomes. Phenome-wide association studies (PheWAS) investigate the association between a wide range of traits and genetic variation. To date, this approach has not been used to investigate the relationship between mtDNA variants and phenotypic variation. Herein, we describe the development of a PheWAS framework for mtDNA variants (mt-PheWAS). Using the Metabochip custom genotyping array, nuclear and mitochondrial DNA variants were genotyped in 11,519 African Americans from the Vanderbilt University biorepository, BioVU. We employed both polygenic modeling and association testing with mitochondrial single nucleotide polymorphisms (mtSNPs) to explore the relationship between mtDNA variants and a group of eight cardiovascular-related traits obtained from de-identified electronic medical records within BioVU. Using polygenic modeling we found evidence for an effect of mtDNA variation on total cholesterol and type 2 diabetes (T2D). After performing comprehensive mitochondrial single SNP associations, we identified an increased number of single mtSNP associations with total cholesterol and T2D compared to the other phenotypes examined, which did not have more significantly associated SNPs than would be expected by chance. Among the mtSNPs significantly associated with T2D we identified variant mt16189, an association previously reported only in Asian and European-descent populations. Our replication of previous findings and identification of novel associations from this initial study suggest that our mt-PheWAS approach is robust for investigating the relationship between mitochondrial genetic variation and a range of phenotypes, providing a framework for future mt-PheWAS.
    BioData Mining 04/2014; 7(1):6. DOI:10.1186/1756-0381-7-6 · 1.54 Impact Factor
Show more